Search for New Antineoplastic Agents Based on Structural Modifications of Steroidal 5α-Reductase, 17β-Hydroxysteroid Dehydrogenase, and 17α-Hydroxylase/17,20-Lyase Inhibitors

    November 2025 in “ Russian Journal of Oncology
    Vladimir А. Zolottsev, Olga Yu. Reshmina, A.M. Korolchuk, A. Yu. Misharin
    Image of study
    TLDR Modifying steroidal inhibitors shows promise for developing new cancer treatments.
    This review explores the optimization of steroidal inhibitors targeting 5α-reductase, 17β-hydroxysteroid dehydrogenase, and 17α-hydroxylase/17,20-lyase to develop new antineoplastic agents. It presents the structures of 209 new compounds and evaluates their therapeutic potential through laboratory and preclinical data. The findings suggest that structural modifications of these steroidal inhibitors are promising for creating new cancer treatments. The review is based on 92 publications sourced from six databases, focusing on existing inhibitors and excluding non-steroidal ones.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 166 results

    Similar Research

    5 / 1000+ results